DE2824064A1 - Phthalazin-derivate, ihre herstellung und solche derivate enthaltende arzneimittel - Google Patents

Phthalazin-derivate, ihre herstellung und solche derivate enthaltende arzneimittel

Info

Publication number
DE2824064A1
DE2824064A1 DE19782824064 DE2824064A DE2824064A1 DE 2824064 A1 DE2824064 A1 DE 2824064A1 DE 19782824064 DE19782824064 DE 19782824064 DE 2824064 A DE2824064 A DE 2824064A DE 2824064 A1 DE2824064 A1 DE 2824064A1
Authority
DE
Germany
Prior art keywords
group
formula
alkyl
compounds
phthalazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19782824064
Other languages
German (de)
English (en)
Inventor
Canterbury Ash
Simon Fraser Dr Campbell
John Christopher Dr Danilewicz
Anthony Garth Dr Evans
Allan Leslie Dr Ham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER
Original Assignee
PFIZER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER filed Critical PFIZER
Publication of DE2824064A1 publication Critical patent/DE2824064A1/de
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE19782824064 1977-06-03 1978-06-01 Phthalazin-derivate, ihre herstellung und solche derivate enthaltende arzneimittel Ceased DE2824064A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2358277 1977-06-03

Publications (1)

Publication Number Publication Date
DE2824064A1 true DE2824064A1 (de) 1978-12-14

Family

ID=10198020

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19782824064 Ceased DE2824064A1 (de) 1977-06-03 1978-06-01 Phthalazin-derivate, ihre herstellung und solche derivate enthaltende arzneimittel

Country Status (29)

Country Link
US (1) US4289772A (OSRAM)
JP (1) JPS5416488A (OSRAM)
AR (2) AR222013A1 (OSRAM)
AT (2) AT362792B (OSRAM)
AU (1) AU505373B1 (OSRAM)
BE (1) BE867727A (OSRAM)
CA (1) CA1111850A (OSRAM)
DD (1) DD137355A5 (OSRAM)
DE (1) DE2824064A1 (OSRAM)
DK (1) DK248078A (OSRAM)
EG (1) EG13527A (OSRAM)
ES (4) ES470470A1 (OSRAM)
FI (1) FI781753A7 (OSRAM)
FR (1) FR2392986A1 (OSRAM)
GB (1) GB2000136B (OSRAM)
GR (1) GR74402B (OSRAM)
HU (1) HU179745B (OSRAM)
IL (1) IL54842A (OSRAM)
IN (3) IN148482B (OSRAM)
IT (1) IT1094944B (OSRAM)
LU (1) LU79761A1 (OSRAM)
NL (1) NL7806016A (OSRAM)
NO (1) NO781935L (OSRAM)
NZ (1) NZ187453A (OSRAM)
PL (3) PL116437B1 (OSRAM)
PT (1) PT68126A (OSRAM)
SE (1) SE7806519L (OSRAM)
SU (2) SU856383A3 (OSRAM)
ZA (1) ZA783183B (OSRAM)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008028689A1 (en) * 2006-09-07 2008-03-13 Bayer Schering Pharma Aktiengesellschaft N-(1-phthalazin-1-ylpiperidin-4-yl)amides as ep2 receptor modulators

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370328A (en) * 1977-11-03 1983-01-25 Pfizer Inc. Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines
IL59619A0 (en) * 1979-03-28 1980-06-30 Pfizer Phthalazine derivatives,their preparation and pharmaceutical compositions containing them
PL129174B1 (en) * 1980-03-01 1984-04-30 Wyeth John & Brother Ltd Process for preparing novel derivatives of piperidine
GB8320958D0 (en) * 1983-08-03 1983-09-07 Pfizer Ltd Quinazoline cardiac stimulants
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
US4882354A (en) * 1987-12-16 1989-11-21 Norwich Eaton Pharmaceuticals, Inc. N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents
US5300515A (en) * 1991-01-31 1994-04-05 Kyorin Pharmaceutical Co., Ltd. Carbamic acid derivatives and method for preparing the same
JP3169188B2 (ja) * 1991-01-31 2001-05-21 杏林製薬株式会社 カルバミン酸誘導体及びその製造方法
EP0621267A1 (en) * 1993-04-07 1994-10-26 Shell Internationale Researchmaatschappij B.V. Spiropiperidine derivatives and their use as fungicides
US5728712A (en) * 1995-05-19 1998-03-17 Chiroscience Limited 3,4-disubstituted-phenylsulphonamides and their therapeutic use
US6288064B1 (en) * 1996-08-20 2001-09-11 Eisai Co., Ltd. Remedy for erection failure comprising fused pyridazine compound
US20030186963A1 (en) 2001-09-14 2003-10-02 Dorwald Florencio Zaragoza Substituted piperidines
JP4554364B2 (ja) * 2002-08-16 2010-09-29 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ インテグリンと選択的に結合するピペリジニル化合物
US20040224986A1 (en) * 2002-08-16 2004-11-11 Bart De Corte Piperidinyl targeting compounds that selectively bind integrins
US20060019975A1 (en) * 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
TW200630337A (en) 2004-10-14 2006-09-01 Euro Celtique Sa Piperidinyl compounds and the use thereof
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス，インコーポレイティド ムスカリン性受容体調節による神経発生
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
WO2007053596A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
BRPI0707223A2 (pt) * 2006-01-27 2011-04-26 Pfizer Prod Inc compostos de derivados de aminoftalazina
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US8247442B2 (en) 2006-03-29 2012-08-21 Purdue Pharma L.P. Benzenesulfonamide compounds and their use
TW200815353A (en) 2006-04-13 2008-04-01 Euro Celtique Sa Benzenesulfonamide compounds and their use
TW200812963A (en) 2006-04-13 2008-03-16 Euro Celtique Sa Benzenesulfonamide compounds and the use thereof
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
EP1903037A1 (de) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft 1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioharnstoffe als Modulatoren des EP2-Rezeptors
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US8399486B2 (en) 2007-04-09 2013-03-19 Purdue Pharma L.P. Benzenesulfonyl compounds and the use thereof
BRPI0815658A2 (pt) 2007-08-07 2015-02-18 Hoffmann La Roche Aril-éter pirrolidina como antagonistas do receptor nk3
AU2008290634B2 (en) 2007-08-22 2012-12-06 F. Hoffmann-La Roche Ag Pyrrolidine aryl-ether as NK3 receptor antagonists
KR101174980B1 (ko) * 2007-09-14 2012-08-17 에프. 호프만-라 로슈 아게 Ｎｋ３ 수용체 길항제로서의 피페리딘 유도체
US8765736B2 (en) 2007-09-28 2014-07-01 Purdue Pharma L.P. Benzenesulfonamide compounds and the use thereof
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
AR077014A1 (es) 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use
US12605377B2 (en) 2020-10-13 2026-04-21 Endeavor Biomedicines, Inc. Methods of treating fibrosis
CN116349204A (zh) 2020-10-13 2023-06-27 奋进生物医药公司 治疗纤维化的方法
CN113087654B (zh) * 2021-04-15 2022-12-23 苏州昊帆生物股份有限公司 哌啶-4-丁胺的制备方法
US12447148B2 (en) 2024-03-05 2025-10-21 Endeavor Biomedicines, Inc. Methods of improving lung function

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1094044A (en) * 1965-07-12 1967-12-06 Vantorex Ltd Phthalazine derivatives
GB1199768A (en) 1966-10-31 1970-07-22 Pfizer & Co C Nitrogen Heterocycles and process for their preparation
GB1293565A (en) * 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
GB1460389A (en) 1974-07-25 1977-01-06 Pfizer Ltd 4-substituted quinazoline cardiac stimulants

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008028689A1 (en) * 2006-09-07 2008-03-13 Bayer Schering Pharma Aktiengesellschaft N-(1-phthalazin-1-ylpiperidin-4-yl)amides as ep2 receptor modulators
EP1900731A1 (de) * 2006-09-07 2008-03-19 Bayer Schering Pharma Aktiengesellschaft N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren

Also Published As

Publication number Publication date
ATA305080A (de) 1980-12-15
IL54842A (en) 1982-01-31
PL207337A1 (pl) 1979-06-04
CA1111850A (en) 1981-11-03
FI781753A7 (fi) 1978-12-04
IN149550B (OSRAM) 1982-01-16
IN149973B (OSRAM) 1982-06-19
GB2000136A (en) 1979-01-04
ES478201A1 (es) 1980-02-01
NZ187453A (en) 1980-12-19
PL116437B1 (en) 1981-06-30
HU179745B (en) 1982-12-28
DD137355A5 (de) 1979-08-29
GR74402B (OSRAM) 1984-06-28
LU79761A1 (fr) 1980-01-22
ES470470A1 (es) 1979-09-01
AT362792B (de) 1981-06-10
BE867727A (fr) 1978-12-01
AT363096B (de) 1981-07-10
SU856383A3 (ru) 1981-08-15
IN148482B (OSRAM) 1981-03-07
SU862826A3 (ru) 1981-09-07
ATA400878A (de) 1980-11-15
US4289772A (en) 1981-09-15
DK248078A (da) 1978-12-04
ES478199A1 (es) 1980-01-16
NL7806016A (nl) 1978-12-05
PL116420B1 (en) 1981-06-30
AR223999A1 (es) 1981-10-15
NO781935L (no) 1978-12-05
SE7806519L (sv) 1978-12-04
IL54842A0 (en) 1978-08-31
GB2000136B (en) 1982-01-06
AR222013A1 (es) 1981-04-15
JPS5538351B2 (OSRAM) 1980-10-03
FR2392986B1 (OSRAM) 1982-07-16
PL113208B1 (en) 1980-11-29
ZA783183B (en) 1979-06-27
FR2392986A1 (fr) 1978-12-29
JPS5416488A (en) 1979-02-07
PT68126A (en) 1978-07-01
AU505373B1 (en) 1979-11-15
EG13527A (en) 1981-12-31
IT1094944B (it) 1985-08-10
ES478200A1 (es) 1980-01-01
IT7824106A0 (it) 1978-06-01

Similar Documents

Publication Publication Date Title
AT363096B (de) Verfahren zur herstellung von neuen phthalazinderivaten und deren salzen
DE69031649T2 (de) Oxoindolderivate
DE69722858T2 (de) Intimale verdickungsinhibitoren
CH645625A5 (de) Benzoesaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel.
DE2530894A1 (de) Chinanzolinderivate
EP0026848A1 (de) Tetralinderivate, ihre Herstellung und Heilmittel, welche diese Verbindungen enthalten
DE2065636A1 (de) Neue tricyclische verbindungen
DE2311570C2 (de) 4-Aminochinoline, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
CH637130A5 (de) Chinazolin-derivate, verfahren zu ihrer herstellung und verwendung dieser derivate in arzneimitteln.
DE2164058B2 (de) Basisch substituierte Benzylphthalazinon-Derivate, ihre Salze, Verfahren zu ihrer Herstellung und diese Produkte enthaltende pharmazeutische Präparate
EP0090369B1 (de) Salicylsäurederivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen und ihre Verwendung
CH649995A5 (de) Piperazinderivate, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten.
DE2816884A1 (de) Anilinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
EP0105210B1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen und ihre Verwendung
DE68916979T2 (de) Alkylen-diamine.
DE2919800A1 (de) 4-amino-2-piperidinochinazolin-derivate, verfahren zu ihrer herstellung und solche derivate enthaltende arzneimittel
DE2211738C3 (de) (2,4-Diallylamino-6-pyrimidinyl)piperazine
DE2410938A1 (de) Chinazolinderivate und diese enthaltende arzneimittel
DE2617955A1 (de) Neue l-substituierte -aroyl-4-hydroxypiperidine, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE1470194C3 (de) 1,3,3-trisubstituierte 4-0mega-(Aminoalkyl) -2-pyrrolidinone und-2-thiopyrrolidinone
DE3424586A1 (de) 3-aminocarbonylmethoxy-5-phenyl-pyrazol-verbindungen sowie verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2107871C3 (OSRAM)
DE3642497A1 (de) Substituierte aminopropionsaeureamide, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung sowie die bei der herstellung anfallenden neuen zwischenprodukte
EP0177907A1 (de) Neue 2-Pyridin-thiol-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE69200840T2 (de) Harnstoff- und Thioharnstoffderivate, Herstellung und therapeutische Verwendung.

Legal Events

Date Code Title Description
OAM Search report available
OC Search report available
OD Request for examination
8131 Rejection